These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1517128)

  • 21. Aggressive drug marketing tactics trigger backlash.
    Singer E
    Nat Med; 2007 Apr; 13(4):393. PubMed ID: 17415363
    [No Abstract]   [Full Text] [Related]  

  • 22. Veterinary drug availability.
    Gloyd J
    J Am Vet Med Assoc; 1980 Apr; 176(7):611-4. PubMed ID: 7372533
    [No Abstract]   [Full Text] [Related]  

  • 23. Marketing food animal practice.
    Herrick JB
    J Am Vet Med Assoc; 1991 Feb; 198(4):546-7. PubMed ID: 2019525
    [No Abstract]   [Full Text] [Related]  

  • 24. More exclusivity means more costs.
    Manz C
    Health Aff (Millwood); 2011 Apr; 30(4):798; author reply 799. PubMed ID: 21471505
    [No Abstract]   [Full Text] [Related]  

  • 25. Societal impact of extending market exclusivity for conventional drugs.
    Musselwhite L; Collingsworth B
    Health Aff (Millwood); 2011 Apr; 30(4):798; author reply 799. PubMed ID: 21471504
    [No Abstract]   [Full Text] [Related]  

  • 26. New drug development in the changing health care environment: a panel discussion.
    Flanagan A; Temple RJ; Wardell WM
    Ann N Y Acad Sci; 1981; 368():203-11. PubMed ID: 6942776
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-effectiveness data on biologics needed.
    Sheridan C; Katsnelson A
    Nat Biotechnol; 2005 Mar; 23(3):272-3. PubMed ID: 15765069
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
    Mahinka SP; Sanzo KM
    Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
    [No Abstract]   [Full Text] [Related]  

  • 29. Comments on the AVMA drug Availability Committee Statement to FDA Commissioner Kennedy.
    Crawford LM
    J Am Vet Med Assoc; 1979 Apr; 174(8):854-6. PubMed ID: 500428
    [No Abstract]   [Full Text] [Related]  

  • 30. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 31. Adopting orphan drugs: Congress tries to encourage new remedies for rare diseases.
    Wallis C
    Time; 1982 Oct; 120(15):76, 79. PubMed ID: 10317248
    [No Abstract]   [Full Text] [Related]  

  • 32. Consumer protection, veterinary medicine, and new animal drugs.
    Kronfeld DS
    J Am Vet Med Assoc; 1972 Dec; 161(11):1395-400. PubMed ID: 4674083
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmaceutical economics and socialist organization science. Drug marketing series. Implication of marketing in the lapse of time in drug studies].
    Alcer G
    Pharm Prax; 1970; 8():169-73. PubMed ID: 5524906
    [No Abstract]   [Full Text] [Related]  

  • 34. The model veterinary drug code--what could it mean?
    McKean JD
    J Am Vet Med Assoc; 1988 Apr; 192(7):885-90. PubMed ID: 3366674
    [No Abstract]   [Full Text] [Related]  

  • 35. The future for third-party payment in veterinary medicine.
    Stephens JL
    J Am Vet Med Assoc; 1999 Apr; 214(7):1010-2. PubMed ID: 10200794
    [No Abstract]   [Full Text] [Related]  

  • 36. A retrospective on 35 years in the animal health industry.
    McClintock TL
    J Am Vet Med Assoc; 1994 Jan; 204(2):193-5. PubMed ID: 8144374
    [No Abstract]   [Full Text] [Related]  

  • 37. The final sampling regulations of the Prescription Drug Marketing Act are alive and well: is your sampling program compliant?
    Romanski JA
    Food Drug Law J; 2003; 58(4):649-60. PubMed ID: 15027455
    [No Abstract]   [Full Text] [Related]  

  • 38. The economic state of specialty practice.
    Burns K
    J Am Vet Med Assoc; 2010 Jun; 236(12):1278-80. PubMed ID: 20550440
    [No Abstract]   [Full Text] [Related]  

  • 39. The pets we love--and drug. Meds for animals are booming. Really.
    Philips M
    Newsweek; 2007 Apr; 149(16):40-1. PubMed ID: 17477155
    [No Abstract]   [Full Text] [Related]  

  • 40. Getting new drugs to market: how individuals could do this without leaving their desks.
    Collier J
    BMJ; 2006 Dec; 333(7582):1315-7. PubMed ID: 17185722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.